Publications of the SFB 1321

Publications



Orthotopic T-cell receptor replacement in primary human T cells using CRISPR-Cas9-mediated homology-directed repair


Moosmann, C., Muller, T. R., Busch, D. H., and Schober, K. (2022). STAR Protoc 3, 101031. DOI: 10.1016/j.xpro.2021.101031

Targeting the undruggable oncogenic KRAS: the dawn of hope


Asimgil, H., Ertetik, U., Cevik, N. C., Ekizce, M., Dogruoz, A., Gokalp, M., Arik-Sever, E., Istvanffy, R., Friess, H., Ceyhan, G. O., and Demir, I. E. (2022). JCI Insight 7

Linking post-translational modifications and protein turnover by site-resolved protein turnover profiling


Zecha, J., Gabriel, W., Spallek, R., Chang, Y. C., Mergner, J., Wilhelm, M., Bassermann, F., and Kuster, B. (2022). Nat Commun 13, 165

Schwann cell-derived exosomes: Janus-faced mediators of regeneration and disease


Wong, F. C., Ye, L., Demir, I. E., and Kahlert, C. (2021). Glia 70, 20-34

Recruitment of highly cytotoxic CD8(+) T cell receptors in mild SARS-CoV-2 infection


Wagner, K. I., Mateyka, L. M., Jarosch, S., Grass, V., Weber, S., Schober, K., Hammel, M., Burrell, T., Kalali, B., Poppert, H., Beyer, H., Schambeck, S., Holdenrieder, S., Strotges-Achatz, A., Haselmann, V., Neumaier, M., Erber, J., Priller, A., Yazici, S., Roggendorf, H., Odendahl, M., Tonn, T., Dick, A., Witter, K., Mijocevic, H., Protzer, U., Knolle, P. A., Pichlmair, A., Crowell, C. S., Gerhard, M., D'Ippolito, E., and Busch, D. H. (2021). Cell Rep, 110214 [Epub ahead of print]

Innervated mouse pancreas organoids as an ex vivo model to study pancreatic neuropathy in pancreatic cancer


Besikcioglu, H. E., Yurteri, U., Munkhbaatar, E., Ye, L., Zhang, F., Moretti, A., Mota Reyes, C., Ozogul, C., Friess, H., Ceyhan, G. O., Istvanffy, R., and Demir, I. E. (2021). STAR Protoc 2, 100935

The Effect of Celiac Neurolysis and Splanchnicectomy on Survival in Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis


Ye, L., Schorn, S., Pergolini, I., Safak, O., Demir, E., Istvanffy, R., Friess, H., Ceyhan, G. O., and Demir, I. E. (2021). Dig Surg, 1-9 [Epub ahead of print]

Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and Resistance


Cintas, C., Douche, T., Dantes, Z., Mouton-Barbosa, E., Bousquet, M. P., Cayron, C., Therville, N., Pont, F., Ramos-Delgado, F., Guyon, C., Garmy-Susini, B., Cappello, P., Burlet-Schiltz, O., Hirsch, E., Gomez-Brouchet, A., Thibault, B., Reichert, M., and Guillermet-Guibert, J. (2021). Mol Cancer Ther 20, 2433-2445

Novel Insights Into Macrophage Diversity During the Course of Pancreatitis


Allawadhi, P., Beyer, G., Mahajan, U. M., and Mayerle, J. (2021). Gastroenterology 161, 1802-1805

Histopathological Tumor and Normal Tissue Responses after 3D-Planned Arc Radiotherapy in an Orthotopic Xenograft Mouse Model of Human Pancreatic Cancer


Dobiasch, S., Kampfer, S., Steiger, K., Schilling, D., Fischer, J. C., Schmid, T. E., Weichert, W., Wilkens, J. J., and Combs, S. E. (2021). Cancers (Basel) 13